Sab Biotherapeutics, Inc. · NASDAQ:SABS

Commodore Capital LP reported a 9.90% stake in Sab Biotherapeutics, Inc. (Schedule 13G)

Event Sep 26, 2025 · Filed Oct 3, 2025

Commodore Capital LP reported a 9.90% stake in Sab Biotherapeutics, Inc., 4,522,977 shares, as a passive investor on Sep 26, 2025. Filed Oct 3, 2025 (Schedule 13G).

Stake
9.90%
Shares
4,522,977
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%4,522,977
Commodore Capital Master LP9.90%4,522,977
Robert Egen Atkinson9.90%4,522,977
Michael Kramarz9.90%4,522,977

Source

View original at SEC

Related